Moenomycin-peptide Complexes to Combat MDR Gram Negative Bacterial Infections
A unique multifunctional approach to expand the spectrum of largely inactive MoeA to target resistant Gram negative bacterial pathogens
Published: 14th April 2022

Patents
- PCT/GB2018/050605
Seeking
- Development partner
- Commercial partner
- Licensing